Gene Therapy Anti-Aging: Tony Huge’s Biohacking Revolution
The longevity revolution is accelerating at breakneck speed, and the latest developments in gene therapy anti-aging research are capturing the attention of biohackers and longevity enthusiasts worldwide. According to a recent report from Observer.com, a pioneering longevity startup is now advancing anti-aging gene therapy into human clinical trials, marking a watershed moment that aligns perfectly […]
GLP-1 Peptides Don’t Cause Muscle Loss: What This Means
A groundbreaking study has challenged one of the most persistent concerns in the bodybuilding and biohacking communities regarding glp-1 receptor agonists. According to recent research reported by NewsNation, GLP-1 use doesn’t contribute to increased muscle loss—a finding that could reshape how performance athletes and body composition enthusiasts approach these powerful peptides. This development is particularly […]
Tirzepatide + HRT: Tony Huge’s Take on Enhanced Weight Loss
Recent groundbreaking research has revealed a compelling connection between menopausal hormone therapy (HRT) and enhanced weight loss outcomes when combined with tirzepatide, offering new insights into hormonal optimization strategies that align with principles long advocated by Tony Huge and the biohacking community. This development represents a significant advancement in understanding how strategic hormone manipulation can […]
Retatrutide And The Glucagon Receptor: The Genetics 23andMe Didn’t Reach
TL;DR Retatrutide is a triple agonist hitting GLP-1, GIP, AND glucagon receptors — the third axis that tirzepatide doesn’t touch and 23andMe’s April 2026 paper didn’t analyze. Primary mechanism: Glucagon receptor (GCGR) activation adds hepatic gluconeogenesis suppression + thermogenic signaling on top of the glp-1/GIP metabolic reprogramming. TRIUMPH-4 numbers: 28.7% mean weight loss at 12mg […]
GLP-1 Pharmacogenomics: The 23andMe Variants That Predict Tirzepatide Side Effects
TL;DR April 2026 Nature paper from 23andMe Research Institute identifies two missense variants — GLP1R rs10305420 (p.Pro7Leu) and GIPR rs1800437 (p.Glu354Gln) — that predict tirzepatide side effects with 14.8x odds ratio for vomiting in double homozygotes. Primary mechanism: Pro7Leu shifts glp-1 receptor signaling bias toward beta-arrestin recruitment (nausea pathway) vs. cAMP (therapeutic pathway); GIPR variant […]
GLP-1 Agonists Then And Now: From Liraglutide With Coach Trevor To LLY’s Quintuple Agonist
TL;DR What it is: Evolution from single glp-1 agonists (liraglutide, semaglutide) to Lilly’s 2026 quintuple agonist targeting GLP-1, GIP, glucagon, amylin, and PYY receptors simultaneously Primary mechanism: Multi-pathway appetite suppression, enhanced insulin sensitivity, direct lipolysis activation, and metabolic rate elevation through independent receptor cascades Who it’s for: Enhanced Men pursuing longevity escape velocity who want […]
GLP-1 Weight Loss Drugs & Muscle Preservation: Analysis
The fitness and bodybuilding community is buzzing with concerns about muscle loss associated with popular GLP-1 weight loss medications like Ozempic and Wegovy. A recent analysis from McMaster University has reignited the debate over whether muscle preservation during glp-1 therapy represents a significant challenge or an overblown concern for physique athletes and bodybuilders. For followers […]
Lilly Halts Muscle-Sparing Obesity Drug: What It Means for Bodybuilders
The pharmaceutical landscape took a surprising turn when eli lilly announced the discontinuation of its promising muscle-sparing obesity drug trial, sending ripples through the bodybuilding and biohacking communities. According to recent reports from BioPharma Dive, this development marks a significant setback in the quest for pharmaceutical solutions that can achieve fat loss while preserving lean […]
GLP-1 Muscle Loss Concerns: What Tony Huge’s Community Needs to Know
The bodybuilding and biohacking community has been buzzing with concerns about glp-1 receptor agonists and their potential impact on muscle mass. However, recent medical insights suggest that fears surrounding GLP-1 muscle loss may be significantly overblown, according to a new report from MDLinx. This development has important implications for Tony Huge’s audience, particularly those exploring […]
HMB Muscle Preservation: Tony Huge’s Take on Obesity Drug Era
As the pharmaceutical industry revolutionizes obesity treatment with powerful new medications, a critical concern has emerged among bodybuilders and fitness enthusiasts: muscle mass preservation. the bodybuilding community, including advocates like tony huge, has long understood that rapid weight loss often comes at the expense of hard-earned muscle tissue. Now, as obesity drugs gain mainstream adoption, […]